Alpha Crest Capital Management LLC Alkermes Plc. Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1.14 Million - $1.65 Million	51,901 Added 213.2%	76,245 $1.7 Million
Q2 2022 Aug 11, 2022	BUY	$26.4 - $30.54 $897 - $1,038	34 Added 0.14%	24,344 $725,000
Q1 2022 May 12, 2022	SELL	$23.07 - $27.99 $1.94 Million - $2.36 Million	-84,165 Reduced 77.59%	24,310 $640,000
Q4 2021 Feb 09, 2022	BUY	$21.47 - $32.08 $1.32 Million - $1.98 Million	61,688 Added 131.85%	108,475 $2.52 Million
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $684,483 - $941,055	29,289 Added 167.38%	46,787 $1.44 Million
Q2 2021 Aug 12, 2021	SELL	$18.78 - $25.15 $1.76 Million - $2.35 Million	-93,608 Reduced 84.25%	17,498 $429,000
Q1 2021 May 13, 2021	BUY	$18.21 - $23.2 $1.57 Million - $2 Million	86,122 Added 344.71%	111,106 $2.08 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $22.1 $49,140 - $70,565	-3,193 Reduced 11.33%	24,984 $498,000
Q3 2020 Nov 12, 2020	BUY	$16.16 - $20.66 $455,340 - $582,136	28,177 New	28,177 $467,000
Q2 2020 Aug 12, 2020	SELL	$13.31 - $19.41 $261,674 - $381,600	-19,660 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$13.06 - $21.24 $15,463 - $25,148	-1,184 Reduced 5.68%	19,660 $283,000
Q4 2019 Feb 12, 2020	SELL	$17.29 - $21.74 $1.02 Million - $1.29 Million	-59,191 Reduced 73.96%	20,844 $425,000
Q3 2019 Nov 12, 2019	SELL	$19.51 - $24.28 $186,300 - $231,849	-9,549 Reduced 10.66%	80,035 $1.56 Million
Q2 2019 Aug 12, 2019	BUY	$21.47 - $37.33 $1.92 Million - $3.34 Million	89,584 New	89,584 $2.02 Million
Q1 2019 May 10, 2019	SELL	$28.4 - $36.49 $842,770 - $1.08 Million	-29,675 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$27.94 - $44.61 $829,119 - $1.32 Million	29,675 New	29,675 $876,000

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$546 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$374 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$364 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$264 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account